RNPEX
Price
$64.62
Change
-$2.05 (-3.07%)
Updated
Dec 18 closing price
RNPHX
Price
$65.29
Change
-$2.07 (-3.07%)
Updated
Dec 18 closing price
Ad is loading...

RNPEX vs RNPHX

Header iconRNPEX vs RNPHX Comparison
Open Charts RNPEX vs RNPHXBanner chart's image
American Funds New Perspective R4
Price$64.62
Change-$2.05 (-3.07%)
VolumeN/A
CapitalizationN/A
American Funds New Perspective R5E
Price$65.29
Change-$2.07 (-3.07%)
VolumeN/A
CapitalizationN/A
RNPEX vs RNPHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RNPEX vs. RNPHX commentary
Dec 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNPEX is a Buy and RNPHX is a Buy.

FUNDAMENTALS
Fundamentals
RNPEX (149B) and RNPHX (149B) have equal amount of cash in the bank . RNPHX pays higher dividends than RNPEX: RNPHX (1.00) vs RNPEX (0.83). RNPEX was incepted earlier than RNPHX: RNPEX (23 years) vs RNPHX (9 years). RNPEX (17.00) and RNPHX (17.00) have comparable annual turnover. RNPEX (250) and RNPHX (250) have matching initial minimum investment requirements. RNPHX (22.41) and RNPEX (22.17) have marching annual gain over last year. RNPHX (46.66) and RNPEX (45.56) have equivalent 5 years return.
RNPEXRNPHXRNPEX / RNPHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years9 years-
Gain YTD21.48321.72099%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets149B149B100%
Annual Yield % from dividends0.831.0083%
Returns for 1 year22.1722.4199%
Returns for 3 years7.227.6994%
Returns for 5 years45.5646.6698%
Returns for 10 years76.05N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EJH0.800.01
+1.65%
E-Home Household Service Holdings Limited
HEPS3.35-0.03
-0.89%
D-Market Electronic Services & Trading
BNTX111.61-5.78
-4.92%
BioNTech SE American Depositary Share
IMVT26.25-1.66
-5.95%
Immunovant
CDTX20.53-2.28
-10.00%
Cidara Therapeutics